| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10594071 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Abstract
Synthesis and biological evaluation of novel and potent cyclohexylamine-based histamine H3 receptor inverse agonists are described. Compounds in this newly identified series exhibited subnanomolar binding affinities for human receptor and no significant interaction with hERG channel. One derivative (10t) demonstrated enhanced in vivo efficiency and preferential brain distribution, both properties suitable for potential clinical evaluation.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Olivier Labeeuw, Nicolas Levoin, Olivia Poupardin-Olivier, Thierry Calmels, Xavier Ligneau, Isabelle Berrebi-Bertrand, Philippe Robert, Jeanne-Marie Lecomte, Jean-Charles Schwartz, Marc Capet,